Healthspan > Lifespan
Modern medicine has successfully extended lifespan, but not always healthspan — the years lived in good health. Too often, we spend our last 15 years in a state of decline.
Optimizing longevity is not just to add years to our life, but also life to our years, by aiming for the 'rectangularization of the curve': maintaining optimal physical and cognitive performance for as long as possible, before a rapid but late decline.
Longevity is not a genetic fate: among twins, genes explain only 20 to 25% of the differences in lifespan. The rest combines chance, environment and habits, part of which can be learned and cultivated. (link )
Rectangularization of the longevity curve
Share of lifespan differences explained by genes, among Danish twins
Chance, environment and habits, only part of which can be changed
The fourteen hallmarks of aging
The landmark work by López-Otín and Kroemer (Cell, 2025) groups the processes of aging into fourteen hallmarks, split into three families: primary, antagonistic, and integrative. This grid frames the entire space of longevity interventions.
Primary hallmarks (causes of damage)
- ·Genomic instability
- ·Telomere attrition
- ·Epigenetic alterations
- ·Loss of proteostasis
- ·Disabled macroautophagy
Antagonistic hallmarks (stress responses)
- ·Deregulated nutrient sensing
- ·Mitochondrial dysfunction
- ·Cellular senescence
Integrative hallmarks (systemic consequences)
- ·Stem cell exhaustion
- ·Altered intercellular communication
- ·Chronic low-grade inflammation
- ·Dysbiosis
- ·Extracellular matrix alterations
- ·Psychosocial isolation
Each pillar of the Handbook acts on one or more of these hallmarks: exercise on mitochondrial function and senescence, nutrition on dysbiosis and nutrient sensing, sleep on intercellular communication and inflammation, and so on.
Medicine 3.0: from cure to anticipation
Modern medicine treats declared disease. Medicine 3.0 — a concept popularized by Peter Attia and rooted in Leroy Hood and Lee Hartwell's P4 medicine — proposes a transition toward a proactive, longitudinal, personalized approach.
Three ages of medicine
- Medicine 1.0. Empirical, observational. From Galen to the late 19th century. Limited understanding of mechanisms.
- Medicine 2.0. Reactive, evidence-based. Born with microbiology (Pasteur, Koch). Excels at treating declared disease but reasons in binary thresholds (healthy / sick).
- Medicine 3.0. Proactive, longitudinal, personalized. Continuous biomarker tracking, intervention on weak signals, optimization before symptoms appear.
The "marginal decade"
Without proactive intervention, the last ten years of life are almost always marked by loss of autonomy, cognition, and muscle mass. The compression of morbidity (Fries, 1980) consists of pushing back this marginal decade by maintaining performance as late as possible.
Read the full analysis : Medicine 3.0: from clinical intervention to proactive optimization
Measure biological age, not just chronological
Chronological age tells you nothing about the actual state of your biology. At 50 chronological years, two people can have a 5 to 10-year gap in biological age. Several approaches now make it possible to objectify this gap.
Five families of tools, complementary
- →Epigenetic clocks (Horvath, GrimAge, DunedinPACE) — DNA methylation at CpG sites, median error 3.6 years for Horvath
- →Composite blood biomarkers (phenotypic age: nine routine markers plus chronological age)
- →Plasma proteomics (Lehallier waves, 2019: signatures at 34, 60, and 78 years)
- →Functional measures (gait speed, grip strength, VO₂ max)
- →Integrated scores combining the approaches above
An exploratory eight-week result
The Fitzgerald pilot trial (2021) tested 8 weeks of an integrated protocol (nutrition, sleep, exercise, stress management, probiotics and phytonutrients). It reported a 3.23-year gap in epigenetic age in favor of the program group. The per-group figures, reported in 2021 and corrected in 2024, show that part of this gap comes from a rise among the controls. An independent reanalysis in 2026 found no significant decrease on any of the eleven added clocks. This exploratory result establishes neither universal kinetics nor a causal effect attributable to any one component; follow-up compares the same test against its repeatability.
The Singular methodology
Singular applies three transversal methodological principles that drive every decision — from the choice of bioactives to the interpretation of biomarkers.
- Hormesis and U-curve. For each essential nutrient, the optimal dose is neither zero nor infinity: too little creates insufficiency, too much creates toxicity. The useful window must be measured, not guessed.
- N=1 biology. Zeevi et al. (Cell, 2015) demonstrated that two people eating the same food can have radically different glycemic responses. The statistical "average" is not an individual. Any standardized approach is by construction suboptimal.
- The five-biomarker method. 25-OH-D, ferritin, serum magnesium, vitamin B12, and hs-CRP alone cover about 80% of supplementation decisions. The sequence (measure, interpret, calibrate, then retest according to each marker's kinetics and uncertainty) matters more than the choice of exotic molecules.
Going further in the Handbook
